Clinical Research Directory
Browse clinical research sites, groups, and studies.
Doxycycline for Helicobacter Pylori Rescue Treatment
Sponsor: Shanghai Jiao Tong University School of Medicine
Summary
Current guidelines have recommended classical bismuth-containing quadruple therapy including proton-pump inhibitor, bismuth, tetracycline, metronidazole as the empirical rescue therapy. However, tetracycline is clinically unavailable in China and the high frequency of adverse events of bismuth quadruple therapy often result in poor compliance, which limited the applicability of this recommendation. This study aimed to compare the efficacy and tolerability of a 14-day bismuth-containing quadruple rescue therapy in which tetracycline was replaced by doxycycline.
Official title: Doxycycline-containing Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
368
Start Date
2023-06-20
Completion Date
2025-10-31
Last Updated
2024-12-30
Healthy Volunteers
No
Conditions
Interventions
Esomeprazole
Proton pump inhibitor
Bismuth Potassium Citrate
Gastric mucosal protective drug with anti-H. pylori effect
Tetracycline
Antibiotics for H. pylori eradication
Doxycycline
Antibiotics for H. pylori eradication
Metronidazole
Antibiotics for H. pylori eradication
Locations (1)
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China